Financial Gravity Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4
| Closed | -$306 | – | 1520 |
|
|
2024
Q1 | $306 | Buy |
+4
| New | +$306 | ﹤0.01% | 1526 |
|
|
2023
Q4 | – | Hold |
0
| – | -$48 | – | 1249 |
|
|
2023
Q3 | – | Sell |
-72
| Closed | -$151 | – | 1051 |
|
|
2023
Q2 | $151 | Buy |
72
+10
| +16% | +$21 | ﹤0.01% | 1231 |
|
|
2023
Q1 | $50 | Sell |
62
-15
| -19% | -$12 | ﹤0.01% | 728 |
|
|
2022
Q4 | $155 | Sell |
77
-58
| -43% | -$117 | ﹤0.01% | 1033 |
|
|
2022
Q3 | $36 | Buy |
+135
| New | +$36 | ﹤0.01% | 675 |
|
|
2021
Q4 | – | Sell |
-1
| Closed | -$33K | – | 964 |
|
|
2021
Q3 | $33K | Hold |
1
| – | – | 0.02% | 682 |
|
|
2021
Q2 | $67K | Buy |
+1
| New | +$67K | 0.02% | 472 |
|